Hôpital Pitié Salpêtrière - AP-HP

85 currently recruiting clinical trials
Create patient profile for matching
Phase 2 Lymphoma #NCT06931652 #2023-505834-84-00
B cell lymphoma Primary cerebral lymphoma Actives > 60 ml/min 50-60 ml/min 30-50 ml/min 1 2 3 or more Chemotherapy
Systemic Treatment-Naive Bispecific T-cell engager antibodies Allogeneic stem cell transplant
Hôpital Pitié Salpêtrière - AP-HP (Paris)
The Lymphoma Academic Research Organisation (LYSARC)
Phase 2 Bladder / Urinary Tract / Urethral cancer #NCT03547973 #2023-508302-24-00
Invasive bladder cancer Urothelial carcinoma Locally Advanced Metastatic None Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Gilead Sciences
Phase 2 Pancreas cancer #NCT04570943
Adenocarcinoma Locally Advanced None Systemic Treatment-Naive Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Lymphoma #NCT06534437 #2024-513098-31-00
B cell lymphoma Large B cell lymphoma Indolent transformed lymphoma None 2 3 or more Chemotherapy Bispecific T-cell engager antibodies Monoclonal antibodies
Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Ryvu Therapeutics SA
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer #NCT05503797 #2024-513578-23-00
Neuroendocrine tumor Locally Advanced Metastatic BRAF 1 2 3 or more
HRAS KRAS G12C KRAS non G12C NRAS Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Fore Biotherapeutics
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT05503797 #2024-513578-23-00
Locally Advanced Metastatic BRAF 1 2 3 or more
KRAS G12C KRAS non G12C NRAS HRAS Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Fore Biotherapeutics
Phase 2 Lymphoma #NCT03328078 #2024-513312-95-00
B cell lymphoma Primary cerebral lymphoma 1 2 3 or more
Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Curis, Inc.
Phase 2 CLL & Richter's syndrome #NCT05963074 #2023-504044-34-00
CLL (Chronic Lymphocytic Leukemia) None None Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Janssen
Phase 2 Lymphoma #NCT05963074 #2023-504044-34-00
B cell lymphoma Lymphocytic lymphoma None None Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Janssen
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT05503797 #2024-513578-23-00
Locally Advanced Metastatic BRAF 1 2 3 or more
KRAS G12C KRAS non G12C NRAS HRAS Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Fore Biotherapeutics